that's generally right but a single patient is unlikely to have multiple cancer types. It will be one cancer type that has spread to multiple sites
- Forums
- ASX - By Stock
- Ann: Phase II study for indication expansion of TLX250-CDx doses
that's generally right but a single patient is unlikely to have...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.04 |
Change
-0.810(4.30%) |
Mkt cap ! $6.048B |
Open | High | Low | Value | Volume |
$18.40 | $18.48 | $17.89 | $16.86M | 934.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 552 | $18.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.05 | 698 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 891 | 18.020 |
12 | 2353 | 18.010 |
12 | 2342 | 18.000 |
12 | 2781 | 17.990 |
9 | 1677 | 17.980 |
Price($) | Vol. | No. |
---|---|---|
18.040 | 425 | 8 |
18.050 | 817 | 9 |
18.060 | 1498 | 14 |
18.070 | 1933 | 11 |
18.080 | 1964 | 7 |
Last trade - 13.16pm 05/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |